MedTrace Logo

Theracurmin vs Curcumin Bioavailability Study

NCT04028739 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2019-12-06

No results posted yet for this study

Summary

A randomized, open-label, cross-over, single administration study to compare bioavailability of curcumin in health adults

Conditions

  • Bioavailability

Interventions

DIETARY_SUPPLEMENT

curmin

curcumin 90mg/day cross-over

Sponsors & Collaborators

  • Handok Inc.

    lead INDUSTRY

Principal Investigators

  • Hyewon Chung · Korea University Guro Hospital

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-07-31
Primary Completion
2019-11-29
Completion
2019-11-29

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04028739 on ClinicalTrials.gov